Evaluated articles

Showing page 293 of 1181 pages of list content

Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

This article has 17 authors:
1. Michael S. Piepenbrink
2. Jun-Gyu Park
3. Ashlesha Desphande
4. Andreas Loos
5. Chengjin Ye
6. Madhubanti Basu
7. Sanghita Sarkar
8. David Chauvin
9. Jennifer Woo
10. Philip Lovalenti
11. Nathaniel B. Erdmann
12. Paul A. Goepfert
13. Vu L. Truong
14. Richard A. Bowen
15. Mark R. Walter
16. Luis Martinez-Sobrido
17. James J. Kobie
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 7, 2022Latest activity Mar 10, 2022
Discovery of Potent Pyrazoline‐Based Covalent SARS‐CoV‐2 Main Protease Inhibitors**

This article has 23 authors:
1. Patrick Moon
2. Charlotte M. Zammit
3. Qian Shao
4. Dustin Dovala
5. Lydia Boike
6. Nathaniel J. Henning
7. Mark Knapp
8. Jessica N. Spradlin
9. Carl C. Ward
10. Helene Wolleb
11. Daniel Fuller
12. Gabrielle Blake
13. Jason P. Murphy
14. Feng Wang
15. Yipin Lu
16. Stephanie A. Moquin
17. Laura Tandeske
18. Matthew J. Hesse
19. Jeffrey M. McKenna
20. John A. Tallarico
21. Markus Schirle
22. F. Dean Toste
23. Daniel K. Nomura
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 3, 2023Latest activity Mar 10, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

This article has 20 authors:
1. Tobias Moll
2. Valerie Odon
3. Calum Harvey
4. Mark O Collins
5. Andrew Peden
6. John Franklin
7. Emily Graves
8. Jack NG Marshall
9. Cleide dos Santos Souza
10. Sai Zhang
11. Lydia Castelli
12. Guillaume Hautbergue
13. Mimoun Azzouz
14. David Gordon
15. Nevan Krogan
16. Laura Ferraiuolo
17. Michael P Snyder
18. Pamela J Shaw
19. Jan Rehwinkel
20. Johnathan Cooper-Knock
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 14, 2022Latest activity Mar 10, 2022
Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity

This article has 8 authors:
1. Julio García-Villalba
2. Laura Hurtado-Navarro
3. Alejandro Peñín-Franch
4. Cristina Molina-López
5. Laura Martínez-Alarcón
6. Diego Angosto-Bazarra
7. Alberto Baroja-Mazo
8. Pablo Pelegrín
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 7, 2022Latest activity Mar 10, 2022
A systematic review about skin lesions in children affected by Coronavirus Disease 2019 (excluding multisystem inflammatory syndrome in children): study protocol

This article has 8 authors:
1. Arianna Dondi
2. Giacomo Sperti
3. Davide Gori
4. Marco Montalti
5. Lorenza Parini
6. Federica Guaraldi
7. Marcello Lanari
8. Iria Neri
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 7, 2022Latest activity Mar 9, 2022
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

This article has 13 authors:
1. Spyros Chalkias
2. Howard Schwartz
3. Biliana Nestorova
4. Jing Feng
5. Ying Chang
6. Honghong Zhou
7. Frank J. Dutko
8. Darin K. Edwards
9. David Montefiori
10. Rolando Pajon
11. Brett Leav
12. Jacqueline M. Miller
13. Rituparna Das
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 7, 2022Latest activity Mar 9, 2022
Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis

This article has 5 authors:
1. Kiera R Murison
2. Alicia A Grima
3. Alison E Simmons
4. Ashleigh R Tuite
5. David N Fisman
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 19, 2022Latest activity Mar 9, 2022
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine

This article has 17 authors:
1. Paul Naaber
2. Liina Tserel
3. Kadri Kangro
4. Marite Punapart
5. Epp Sepp
6. Virge Jürjenson
7. Jaanika Kärner
8. Liis Haljasmägi
9. Uku Haljasorg
10. Marilin Kuusk
11. Eve Sankovski
12. Anu Planken
13. Mart Ustav
14. Eva Žusinaite
15. Joachim M. Gerhold
16. Kai Kisand
17. Pärt Peterson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 1, 2022Latest activity Mar 9, 2022
Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response

This article has 8 authors:
1. Miriam Hernández Porto
2. Teresa Delgado
3. Armando Aguirre-Jaime
4. María Jose Ramos
5. Silvia Campos
6. Orlando Acosta
7. Ana Belén Llanos
8. María Lecuona
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 7, 2022Latest activity Mar 9, 2022
Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients

This article has 18 authors:
1. Alina Bauer
2. Elisabeth Pachl
3. Johannes C. Hellmuth
4. Nikolaus Kneidinger
5. Marion Frankenberger
6. Hans C. Stubbe
7. Bernhard Ryffel
8. Agnese Petrera
9. Stefanie M. Hauck
10. Jürgen Behr
11. Rainer Kaiser
12. Clemens Scherer
13. Li Deng
14. Daniel Teupser
15. Narges Ahmidi
16. Maximilian Muenchhoff
17. Benjamin Schubert
18. Anne Hilgendorff
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 6, 2022Latest activity Mar 9, 2022
Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities

This article has 8 authors:
1. Margaret L Lind
2. Olivia L Schultes
3. Alexander J Robertson
4. Amy J Houde
5. Derek A T Cummings
6. Albert I Ko
7. Byron S Kennedy
8. Robert P Richeson
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 6, 2022Latest activity Mar 9, 2022
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3 ^rd mRNA Vaccine Dose

This article has 10 authors:
1. Alexa J. Roeder
2. Megan A. Koehler
3. Sergei Svarovsky
4. Paniz Jasbi
5. Alim Seit-Nebi
6. Maria J. Gonzalez-Moa
7. John Vanderhoof
8. Davis McKechnie
9. Baylee A. Edwards
10. Douglas F. Lake
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 6, 2022Latest activity Mar 9, 2022
Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children

This article has 36 authors:
1. Rinaldo Puga-Gómez
2. Yariset Ricardo-Delgado
3. Chaumey Rojas-Iriarte
4. Leyanis Céspedes-Henriquez
5. Misleidys Piedra-Bello
6. Dania Vega-Mendoza
7. Noelvia Pestana Pérez
8. Beatriz Paredes-Moreno
9. Meiby Rodríguez-González
10. Carmen Valenzuela-Silva
11. Belinda Sánchez-Ramírez
12. Laura Rodríguez-Noda
13. Rocmira Pérez-Nicado
14. Raul González-Mugica
15. Tays Hernández-García
16. Talía Fundora-Barrios
17. Martha Dubet Echevarría
18. Juliet María Enriquez-Puertas
19. Yenicet Infante Hernández
20. Ariel Palenzuela-Díaz
21. Evelyn Gato-Orozco
22. Yanet Chappi-Estévez
23. Julio Cesar Francisco-Pérez
24. Miladi Suarez Martinez
25. Ismavy C. Castillo-Quintana
26. Sonsire Fernandez-Castillo
27. Yanet Climent-Ruiz
28. Darielys Santana-Mederos
29. Yanelda García-Vega
30. María Eugenia Toledo-Romani
31. Delaram Doroud
32. Alireza Biglari
33. Yury Valdés-Balbín
34. Dagmar García-Rivera
35. Vicente Vérez-Bencomo
36. SOBERANA Research Group
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 6, 2022Latest activity Mar 9, 2022
SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

This article has 8 authors:
1. Nathalie de Visscher
2. Xavier Holemans
3. Aline Gillain
4. Anne Kornreich
5. Raphael Lagasse
6. Philippe Piette
7. Manfredi Ventura
8. Frédéric Thys
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 14, 2022Latest activity Mar 9, 2022
Development of a COVID-19 risk assessment model for participants at outdoor music festivals: evaluation of the validity and control measure effectiveness based on two actual events in Japan and Spain

This article has 5 authors:
1. Michio Murakami
2. Tsukasa Fujita
3. Pinqi Li
4. Seiya Imoto
5. Tetsuo Yasutaka
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 8, 2022Latest activity Mar 9, 2022
Assessment of aerosol persistence in ICUs via low-cost sensor network and zonal models

This article has 6 authors:
1. K. Glenn
2. J. He
3. R. Rochlin
4. S. Teng
5. J. G. Hecker
6. I. Novosselov
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 10, 2023Latest activity Mar 9, 2022
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

This article has 11 authors:
1. Elise J. Kuylen
2. Andrea Torneri
3. Lander Willem
4. Pieter J. K. Libin
5. Steven Abrams
6. Pietro Coletti
7. Nicolas Franco
8. Frederik Verelst
9. Philippe Beutels
10. Jori Liesenborgs
11. Niel Hens
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 22, 2022Latest activity Mar 8, 2022
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

This article has 11 authors:
1. Masaharu Shinkai
2. Takuhiro Sonoyama
3. Akari Kamitani
4. Risa Yokokawa Shibata
5. Naomi M. Seki
6. Shinya Omoto
7. Masahiro Shinoda
8. Takashi Sato
9. Naoki Ishii
10. Kenji Igarashi
11. Mari Ariyasu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 1, 2022Latest activity Mar 8, 2022
Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes

This article has 4 authors:
1. Hu Li
2. Zhiwei Chen
3. Xiaoqing Liu
4. Peng Hu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 6, 2022Latest activity Mar 8, 2022
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

This article has 10 authors:
1. Suvimol Niyomnaitham
2. Zheng Quan Toh
3. Patimaporn Wongprompitak
4. Laddawan Jansarikit
5. Kanjana Srisutthisamphan
6. Sompong Sapsutthipas
7. Yuparat Jantraphakorn
8. Natthakarn Mingngamsup
9. Paul V Licciardi
10. Kulkanya Chokephaibulkit
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 11, 2022Latest activity Mar 8, 2022